Skip to main content

BioConsortia's most recent funding was $15 million

BioConsortia Inc. has raised $15 million to conduct hundreds of field trials using its biotechnology this year with third-party partners in fields in North America, Asia, Latin America and Europe.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.